mequinol has been researched along with thiazoles in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Espín, JC; García-Cánovas, F; Tudela, J; Varón, R | 1 |
Fenoll, LG; García-Cánovas, F; García-Ruiz, PA; Rodríguez-López, JN; Tudela, J; Varón, R | 1 |
Lapp, CA; Schuster, GS | 1 |
Dicko, MH; Gruppen, H; Hilhorst, R; Laane, C; van Berkel, WJ; Voragen, AG | 1 |
Hussar, DA | 1 |
5 other study(ies) available for mequinol and thiazoles
Article | Year |
---|---|
Kinetic study of the oxidation of 4-hydroxyanisole catalyzed by tyrosinase.
Topics: Anisoles; Benzothiazoles; Catalysis; Hydrazones; Hydrogen-Ion Concentration; Kinetics; Monophenol Monooxygenase; Oxidation-Reduction; Phenols; Regression Analysis; Spectrophotometry; Substrate Specificity; Thiazoles | 1997 |
Kinetic study of the oxidation of 3-hydroxyanisole catalysed by tyrosinase.
Topics: Agaricales; Anisoles; Benzothiazoles; Catalysis; Hydrazones; Hydroxylation; Isomerism; Kinetics; Monophenol Monooxygenase; Nuclear Magnetic Resonance, Biomolecular; Oxidation-Reduction; Thiazoles | 2000 |
Effects of DMAEMA and 4-methoxyphenol on gingival fibroblast growth, metabolism, and response to interleukin-1.
Topics: Anisoles; Antioxidants; Cell Division; Cells, Cultured; Fibroblasts; Gentian Violet; Gingiva; Humans; Interleukin-1; Methacrylates; Mitochondria; Reducing Agents; Tetrazolium Salts; Thiazoles | 2002 |
Zymography of monophenolase and o-diphenolase activities of polyphenol oxidase.
Topics: Anisoles; Benzothiazoles; Caffeic Acids; Catechol Oxidase; Edible Grain; Hydrazones; Oxidoreductases; Quinones; Spectrophotometry; Thiazoles | 2002 |
New drugs 04, part 1.
Topics: Adalimumab; Alefacept; alpha-Galactosidase; Anisoles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Antirheumatic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Approval; Drug Therapy; Fabry Disease; Gefitinib; Humans; Iduronidase; Indoles; Isoenzymes; Lentigo; Lung Neoplasms; Migraine Disorders; Mucopolysaccharidosis I; Nitro Compounds; Patient Education as Topic; Propylamines; Psoriasis; Pyrrolidines; Quinazolines; Recombinant Fusion Proteins; Serotonin Receptor Agonists; Thiazoles; Tryptamines | 2004 |